Skip to main content
. 2017 Feb 1;8(10):16531–16552. doi: 10.18632/oncotarget.14972

Figure 3. Meta-analysis evaluating the relationships between AEG-1 expression and clinicopathological parameters in patients with NSCLC.

Figure 3

(A) Clinical stage (OR=3.23, 95%CI: 2.41–4.33, P < 0.001). (B) Lymph node metastasis (OR = 2.24, 95%CI: 1.76–2.84, P < 0.001). (C) Distant metastasis (OR=3.39, 95%CI: 1.85–6.23, P < 0.001). (D) Histological differentiation (OR = 1.77, 95%CI: 1.17–2.69, P = 0.007). (E) Age (OR = 1.01, 95%CI: 0.80–1.28, P = 0.937).(F) Gender (OR =1.28, 95%CI: 1.00–1.63, P = 0.054).